# Farmers National Banc Corp: overview

FMNB · Nasdaq · CIK 709337 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fmnb.md) · [Financials](/companies/fmnb/financials.md) · [Filings](/companies/fmnb/filings.md) · [Insiders](/companies/fmnb/insiders.md)

Latest reported revenue: [$100.5m](/filings/0001437749-26-026085.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001437749-26-026085).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [70.3](/filings/0001437749-25-033486.md) | [69.3 d](/filings/0001437749-26-007084.md) | [67.8](/filings/0001437749-26-015423.md) | [69.8](/filings/0001437749-26-026085.md) | [70.8](/filings/0001437749-25-033486.md) | [71.5 d](/filings/0001437749-26-007084.md) | [80.8](/filings/0001437749-26-015423.md) | [101](/filings/0001437749-26-026085.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [12.1%](/filings/0001437749-25-033486.md) | [20.8% d](/filings/0001437749-26-007084.md) | [20.0%](/filings/0001437749-26-026085.md) | [19.9%](/filings/0001437749-26-026085.md) | [17.6%](/filings/0001437749-25-033486.md) | [20.5% d](/filings/0001437749-26-007084.md) | [20.1%](/filings/0001437749-26-026085.md) | [22.9%](/filings/0001437749-26-026085.md) |
| Diluted EPS | $ per share | [0.23](/filings/0001437749-25-033486.md) | not reported | [0.36](/filings/0001437749-26-015423.md) | [0.37](/filings/0001437749-26-026085.md) | [0.33](/filings/0001437749-25-033486.md) | not reported | [0.36](/filings/0001437749-26-015423.md) | [0.39](/filings/0001437749-26-026085.md) |
| Free cash flow | $m | [20.4 d](/filings/0001437749-25-033486.md) | [8.0 d](/filings/0001437749-26-007084.md) | [12.2](/filings/0001437749-26-015423.md) | [12.4 d](/filings/0001437749-26-026085.md) | [9.0 d](/filings/0001437749-25-033486.md) | [18.6 d](/filings/0001437749-26-007084.md) | [7.1](/filings/0001437749-26-015423.md) | [26.0 d](/filings/0001437749-26-026085.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [186](/filings/0000950170-25-034480.md) | [255](/filings/0001437749-26-007084.md) | [269](/filings/0001437749-26-007084.md) | [280](/filings/0001437749-26-007084.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | [32.5%](/filings/0000950170-25-034480.md) | [19.6%](/filings/0001437749-26-007084.md) | [17.1%](/filings/0001437749-26-007084.md) | [19.5%](/filings/0001437749-26-007084.md) |
| Diluted EPS | $ per share | [1.77](/filings/0000950170-24-027780.md) | [1.79](/filings/0000950170-25-034480.md) | [1.33](/filings/0001437749-26-007084.md) | [1.22](/filings/0001437749-26-007084.md) | [1.45](/filings/0001437749-26-007084.md) |
| Free cash flow | $m | [53.6](/filings/0000950170-24-027780.md) | [78.9](/filings/0000950170-25-034480.md) | [59.0](/filings/0001437749-26-007084.md) | [54.9](/filings/0001437749-26-007084.md) | [52.2](/filings/0001437749-26-007084.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fmnb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $70.1m | 4,798,011 |  | Added +569,057 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $36.3m | 2,483,972 |  | Added +21,812 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $29.1m | 1,989,971 |  | Added +746,719 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $22.9m | 1,570,222 |  | Added +30,388 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $22.3m | 1,523,677 |  | Added +147,028 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $12.2m | 832,287 |  | Added +493,398 |
| [FARMERS TRUST CO](/funds/1318055.md) | 2026-03-31 | $9.5m | 724,473 |  | Not compared |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $8.8m | 599,937 |  | Added +67,106 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $7.7m | 530,430 |  | Added +97,891 |
| [HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC](/funds/1164833.md) | 2026-06-30 | $7.4m | 504,386 |  | Added +2,500 |

## Recent filings

[All 2,169 filings](/companies/fmnb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 08:00 ET | [8-K](/filings/0001437749-26-033702.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-033702 |
| 2026-09-18 | 16:33 ET | [8-K](/filings/0001437749-26-030756.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-030756 |
| 2026-08-06 | 10:11 ET | [10-Q](/filings/0001437749-26-026085.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026085 |
| 2026-07-22 | 08:05 ET | [8-K](/filings/0001437749-26-024042.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-024042 |
| 2026-05-12 | 15:23 ET | [8-K/A](/filings/0001437749-26-016395.md) | 9.01 Financial statements and exhibits | 0001437749-26-016395 |
| 2026-05-07 | 11:16 ET | [10-Q](/filings/0001437749-26-015423.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015423 |
| 2026-04-22 | 07:56 ET | [8-K](/filings/0001437749-26-012964.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012964 |
| 2026-04-16 | 16:21 ET | [8-K](/filings/0001437749-26-012568.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-012568 |
| 2026-03-17 | 16:04 ET | [10-K/A](/filings/0001437749-26-008599.md) | Annual report, amended, period 2025-12-31 | 0001437749-26-008599 |
| 2026-03-17 | 08:00 ET | [8-K](/filings/0001437749-26-008505.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-008505 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-007084.md), filed Mar 5, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/15db3c61-6ce1-441d-be02-4a08362f946c)

## About the filer

- CIK: 709337
- Tickers: FMNB
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: OH
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:47 ET. No prices; not investment advice.